Radical Neck Dissection — Procedure Guide, Recovery & Risks | MyMedicPlus

Radical neck dissection (RND) is the most extensive cervical lymph node clearance procedure, involving en-bloc removal of all ipsilateral cervical lymph node groups (Levels I through V) together with three non-lymphatic structures: the sternocleidomastoid muscle (SCM), the internal jugular vein (IJV), and the spinal accessory nerve (cranial nerve XI). First codified by George Crile Sr. in 1906 based on his work at Cleveland Clinic, radical neck dissection became the standard surgical treatment for cervical lymph node metastases from head and neck squamous cell carcinoma throughout the 20th century.

The cervical lymph nodes are the primary regional drainage basin for malignancies of the oral cavity, oropharynx, hypopharynx, larynx, thyroid, parotid gland, and skin of the head and neck. Metastatic spread to cervical lymph nodes significantly worsens prognosis and requires aggressive treatment. Radical neck dissection achieves maximum clearance of regional disease at the cost of significant functional morbidity from sacrifice of the three non-lymphatic structures.

Modern neck dissection practice has shifted decisively toward modified radical neck dissection (MRND), which preserves one or more non-lymphatic structures — most commonly the spinal accessory nerve — while maintaining equivalent oncologic control for the majority of patients. Classical radical neck dissection is now reserved for cases where tumour directly invades the SCM, IJV, or CN XI, making preservation oncologically unsafe.

Radical neck dissection is indicated when cervical lymph node metastases from head and neck cancer directly involve or are inseparable from the sternocleidomastoid muscle, internal jugular vein, or spinal accessory nerve, making the functionally superior modified radical or selective dissection inadequate to achieve clear resection margins.

Primary oncological indications include: (1) Head and neck squamous cell carcinoma (oral cavity, oropharynx, hypopharynx, larynx) with multiple or bulky cervical lymph node metastases (N2c or N3 disease) where nodal fixation or extracapsular extension involves adjacent non-lymphatic structures; (2) Thyroid malignancies (particularly anaplastic or advanced papillary carcinoma) with gross nodal disease encasing the carotid sheath structures; (3) Parotid or submandibular salivary gland malignancies with cervical nodal involvement and adjacent muscle or vascular encasement; (4) Recurrent head and neck cancer after prior surgery or radiotherapy where the recurrence involves the neck vasculature or musculature.

Modified radical neck dissection type III (preserving SCM, IJV, and CN XI) or selective neck dissection is preferred whenever oncologically safe, as they provide equivalent regional control with substantially better functional outcomes. The decision between radical and modified radical dissection is made intraoperatively based on the degree of nodal fixation encountered, and surgeons typically begin with a modified approach and escalate to radical if necessary.

Neoadjuvant chemoradiotherapy for selected locally advanced tumours may render previously fixed nodes operable with a less extensive dissection, and is considered in the multidisciplinary team setting before planning surgery.

Radical neck dissection is performed under general anaesthesia with the patient supine, neck extended and head rotated to the contralateral side. Prophylactic antibiotics covering oral flora are given at induction.

Surgical steps:

1. **Incision:** A large transverse or modified MacFee (two horizontal) incision is made to provide wide exposure of the entire neck from mastoid to midline. The incision must avoid skin flap ischaemia, particularly if post-operative radiotherapy is anticipated.

1. **Skin flap elevation:** Superior and inferior skin flaps are elevated in the subplatysmal plane to expose the entire neck from the mandible to the clavicle, from midline to the posterior triangle.

1. **SCM detachment:** The sternocleidomastoid muscle is divided at its sternal and clavicular origins inferiorly and at its mastoid process insertion superiorly, and retracted with the specimen.

1. **IJV ligation:** The internal jugular vein is identified, isolated, doubly ligated with non-absorbable sutures, and divided at both ends — at the jugular foramen superiorly and at the subclavian/brachiocephalic junction inferiorly. Bilateral IJV ligation is avoided due to risk of cerebral venous hypertension.

1. **CN XI division:** The spinal accessory nerve is identified as it exits the jugular foramen and divided, removing it with the specimen.

1. **Nodal clearance:** All five cervical lymph node levels are dissected, maintaining the fascia-enclosed specimen. Key structures preserved include the common carotid artery, vagus nerve (CN X), phrenic nerve, brachial plexus, hypoglossal nerve (CN XII), marginal mandibular branch of CN VII, and lingual artery.

1. **Haemostasis and closure:** Meticulous haemostasis is achieved. One or two closed-suction drains are placed. The skin is closed in layers with absorbable deep sutures and interrupted non-absorbable skin sutures.

Radical neck dissection achieves comprehensive regional disease control for head and neck malignancies with direct non-lymphatic structure involvement, where less extensive dissection would leave positive margins.

Regional control rates: In N2 and N3 disease managed with radical neck dissection followed by adjuvant radiotherapy or chemoradiotherapy, 5-year regional control rates of 70–80% are achievable. For N1 disease with adequate margin, regional control exceeds 85–90%.

Comparison with modified radical neck dissection: Multiple prospective studies and meta-analyses have confirmed that modified radical neck dissection type III (preserving SCM, IJV, and CN XI) provides equivalent oncologic regional control to classical radical neck dissection for N1 and N2a nodal disease in head and neck cancer, with significantly superior functional outcomes. MRND is therefore preferred for all patients where it is oncologically safe, and radical neck dissection is reserved for the approximately 10–20% of cases where direct structural invasion necessitates a more extensive approach.

Survival: Five-year overall survival for head and neck cancer with cervical nodal disease treated with curative intent (surgery and adjuvant therapy) ranges from 40–70% depending on primary tumour site, T and N stage, HPV status (oropharyngeal cancer), and histological risk factors including extracapsular nodal extension and perineural invasion.

The morbidity of radical neck dissection is substantially higher than modified or selective dissection due to obligatory sacrifice of the spinal accessory nerve, sternocleidomastoid muscle, and internal jugular vein.

Neurological complications: - Spinal accessory nerve (CN XI) sacrifice: Causes ipsilateral trapezius muscle denervation, resulting in shoulder drop, lateral scapular winging, and chronic shoulder pain in 50–70% of patients. Physiotherapy can partially compensate but permanent functional deficit is common. - Marginal mandibular nerve injury (CN VII branch): Causes ipsilateral lower lip and corner-of-mouth weakness, occurring in 5–15% from surgical traction. - Sympathetic chain injury: Causes ipsilateral Horner syndrome (ptosis, miosis, anhidrosis) in under 5%. - Hypoglossal (CN XII) or lingual nerve injury: Tongue deviation or anaesthesia in under 3%.

Vascular complications: - Chyle leak from thoracic duct injury: Occurs in 1–3% of left-sided dissections, presenting as milky or increased drain output. Managed conservatively with low-fat diet or nil by mouth, but may require re-exploration. - Carotid artery exposure: If the overlying skin is thin or a wound breakdown occurs (particularly post-radiotherapy), carotid blowout is a life-threatening emergency managed with urgent endovascular or open repair. - Haematoma requiring surgical evacuation: 2–5%.

Other complications: - Wound infection: 5–10%, higher in patients previously irradiated. - Lymphoedema of the face and neck from jugular vein ligation — transient facial oedema is common and usually resolves within 2–4 weeks. - Postoperative seroma: 5–10%, managed with aspiration.

Recovery from radical neck dissection requires careful wound management, early physiotherapy for shoulder rehabilitation, and coordination of adjuvant oncological therapy.

Hospital phase (Days 0–7): Hospital stay is 5–7 days. Closed-suction drains remain until output falls below 30 mL per 24 hours, typically 5–7 days. Transient facial and neck oedema from internal jugular vein ligation is monitored — this usually resolves within 2–4 weeks. Oral feeding begins within 24–48 hours unless combined with primary tumour resection. Sutures or staples are removed at 10–14 days.

Early rehabilitation (Weeks 2–6): Shoulder physiotherapy begins immediately post-operatively to compensate for trapezius weakness from spinal accessory nerve sacrifice. A specialist physiotherapist teaches shoulder strengthening exercises targeting levator scapulae, rhomboids, and serratus anterior to compensate for lost trapezius function. Many patients achieve useful compensatory shoulder stability with dedicated rehabilitation.

Adjuvant therapy (Weeks 6–12): Adjuvant radiotherapy to the primary site and neck is standard for N2–N3 disease, positive surgical margins, or extracapsular nodal extension. Concurrent cisplatin chemotherapy is added for high-risk pathological features. Radiotherapy begins 6–8 weeks post-operatively once the wound has healed adequately. Post-radiotherapy neck fibrosis may further restrict neck and shoulder movement, emphasising the importance of ongoing physiotherapy.

Long-term follow-up: Oncological surveillance for recurrence includes clinical examination, fibreoptic laryngoscopy, and imaging (CT or PET-CT) at 3, 6, and 12 months and annually thereafter. Patients experiencing wound or vascular complications, particularly those who have received radiotherapy, require close long-term wound surveillance.